Inhibition of NF‐κB may enhance the cancer treatment response to most traditional treatments and treatments developed in recent years such as immune checkpoint inhibitors; however, long‐term inhibition of the NF‐κB pathway perhaps causes serious side effects, especially impaired immune response and compensated anti‐tumor immune function.423. Here, NFKB1 is linked to cancer.